Topical Treatment For Athlete's Foot Therapeutics
1. Ertaczo patent expiration
Treatment: Product is approved for the topical treatment of tinea pedis
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5135943 | LACER PHARMA | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same |
May, 2014
(11 years ago) | |
Drugs and Companies using SERTACONAZOLE NITRATE ingredient
Market Authorisation Date: 10 December, 2003
Dosage: CREAM
More Information on Dosage
ERTACZO family patents
